Whilst recent studies have made progress in identifying oncogenic JNK complexes that regulate cancer stem cell populations in gastric and breast cancers, significantly more work is required to therapeutically target these complexes, and resolve the composition, organization and interfaces of JNK complexes that drive tumorigenesis and metastatic disease progression in other tumor types. The gene discussed is MAPK8; the disease is metastatic neoplasm.